ResearcherSpectrum HealthActive in the last 2 years
Gerald Paul Wright
Matched on ORCID iD 0000-0001-9299-0408; OpenAlex author ID A5044711381. Sources: ClinicalTrials.gov.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2016: 2 papers · 2017: none · 2018: none · 2019: 1 trial · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 5
- Neoadjuvant Chemotherapy and Radiation Improves Recurrence-free and Overall Survival in Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1177/00031348241250043↗
- Pancreatic Cancer: A Review of Current Treatment and Novel Therapies. Co-author DOI 10.1080/08941939.2022.2129884↗
- Recurrence patterns and postrecurrence survival after curative intent resection for pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.surg.2020.06.042↗
- Primary Tumor Resection Following Favorable Response to Systemic Chemotherapy in Stage IV Pancreatic Adenocarcinoma with Synchronous Metastases: a Bi-instituti… Co-author DOI 10.1007/s11605-016-3256-2↗
- Using next-generation sequencing to determine potential molecularly guided therapy options for patients with resectable pancreatic adenocarcinoma. Co-author DOI 10.1016/j.amjsurg.2015.11.002↗
Trials 1
- Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases Principal investigator NCT03856658↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mathew H. Chung · 4 shared papers, 2016–2024 · strength 0.71
- Paper Pancreatic Cancer: A Review of Current Treatment and Novel Therapies. DOI 10.1080/08941939.2022.2129884↗
- Paper Neoadjuvant Chemotherapy and Radiation Improves Recurrence-free and Overall Survival in Resectable and Borderline Resec… DOI 10.1177/00031348241250043↗
- Paper Recurrence patterns and postrecurrence survival after curative intent resection for pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2020.06.042↗
- Hordur Mar Kolbeinsson · 3 shared papers, 2021–2024 · strength 0.62
- Paper Pancreatic Cancer: A Review of Current Treatment and Novel Therapies. DOI 10.1080/08941939.2022.2129884↗
- Paper Neoadjuvant Chemotherapy and Radiation Improves Recurrence-free and Overall Survival in Resectable and Borderline Resec… DOI 10.1177/00031348241250043↗
- Paper Recurrence patterns and postrecurrence survival after curative intent resection for pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2020.06.042↗
- Sreenivasa Rao Chandana · 2 shared papers, 2023–2024 · strength 0.48
- M. Mura Assifi · 2 shared papers, 2021–2024 · strength 0.35
- Paper Neoadjuvant Chemotherapy and Radiation Improves Recurrence-free and Overall Survival in Resectable and Borderline Resec… DOI 10.1177/00031348241250043↗
- Paper Recurrence patterns and postrecurrence survival after curative intent resection for pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2020.06.042↗
- Jesse K. Kelley · 1 shared paper, 2024 · strength 0.22
- Melissa Ellen Hogg · 1 shared paper, 2016 · strength 0.06
- Christopher Lee Wolfgang · 1 shared paper, 2016 · strength 0.06
- Herbert J. Zeh · 1 shared paper, 2016 · strength 0.06
- Matthew John Weiss · 1 shared paper, 2016 · strength 0.06
- Nathan Bahary · 1 shared paper, 2016 · strength 0.06
- Katherine E. Poruk · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.